INOVIO PHARMACEUTICALS, INC. Other Nonoperating Income (Expense)
INOVIO PHARMACEUTICALS, INC. (INO) reported Other Nonoperating Income (Expense) of -$1.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$1.71M.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$285.49K.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $88.00.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$1.94M.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2025 was -$2.64M.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2024 was -$3.16M.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2023 was -$4.71M.
- INOVIO PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2022 was -$3.86M, a 1224.61% decline from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.71M 10-Q · filed 2026-08-12 | -$2.00M 10-Q · filed 2026-08-12 | -$2.00M derived: sum of 3 quarters · filed 2026-08-12 | -$3.94M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$285.49K 10-Q · filed 2026-05-13 | -$285.40K derived: sum of 2 quarters · filed 2026-05-13 | -$2.22M derived: sum of 3 quarters · filed 2026-05-13 | -$2.93M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $88.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.94M derived: sum of 2 quarters · filed 2026-03-12 | -$2.64M derived: sum of 3 quarters · filed 2026-08-12 | -$2.64M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$1.94M 10-Q · filed 2025-11-10 | -$2.64M derived: sum of 2 quarters · filed 2026-08-12 | -$2.64M 10-Q · filed 2025-11-10 | -$4.55M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$703.18K 10-Q · filed 2026-08-12 | -$703.66K 10-Q · filed 2026-08-12 | -$2.61M derived: sum of 3 quarters · filed 2026-08-12 | -$3.19M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$482.00 10-Q · filed 2026-05-13 | -$1.91M derived: sum of 2 quarters · filed 2026-05-13 | -$2.49M derived: sum of 3 quarters · filed 2026-05-13 | -$2.48M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.49M derived: sum of 2 quarters · filed 2026-03-12 | -$2.48M derived: sum of 3 quarters · filed 2026-03-12 | -$3.16M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$579.82K 10-Q · filed 2025-11-10 | -$572.25K derived: sum of 2 quarters · filed 2025-11-10 | -$1.25M 10-Q · filed 2025-11-10 | -$2.12M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $7.57K 10-Q · filed 2025-08-12 | -$674.65K 10-Q · filed 2025-08-12 | -$1.54M derived: sum of 3 quarters · filed 2025-08-12 | -$1.53M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$682.22K 10-Q · filed 2025-05-13 | -$1.54M derived: sum of 2 quarters · filed 2025-05-13 | -$1.54M derived: sum of 3 quarters · filed 2025-05-13 | -$2.97M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$860.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$858.05K derived: sum of 2 quarters · filed 2025-03-18 | -$2.29M derived: sum of 3 quarters · filed 2025-03-18 | -$4.71M 10-K · filed 2025-03-18 |
| 2023-09-30 | $2.85K 10-Q · filed 2024-11-14 | -$1.43M derived: sum of 2 quarters · filed 2024-11-14 | -$3.85M 10-Q · filed 2024-11-14 | -$6.61M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.43M 10-Q · filed 2024-08-08 | -$3.85M 10-Q · filed 2024-08-08 | -$6.62M derived: sum of 3 quarters · filed 2024-08-08 | -$7.56M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$2.43M 10-Q · filed 2024-05-13 | -$5.19M derived: sum of 2 quarters · filed 2024-05-13 | -$6.13M derived: sum of 3 quarters · filed 2024-05-13 | -$6.13M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$3.71M derived: sum of 2 quarters · filed 2024-03-06 | -$3.71M derived: sum of 3 quarters · filed 2024-03-06 | -$3.86M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$940.78K 10-Q · filed 2023-11-09 | -$943.83K derived: sum of 2 quarters · filed 2023-11-09 | -$1.10M 10-Q · filed 2023-11-09 | -$919.70K derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | -$3.05K 10-Q · filed 2023-08-09 | -$156.52K 10-Q · filed 2023-08-09 | $21.08K derived: sum of 3 quarters · filed 2024-03-06 | -$7.40K derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | -$153.47K 10-Q · filed 2023-05-10 | $24.13K derived: sum of 2 quarters · filed 2024-03-06 | -$4.36K derived: sum of 3 quarters · filed 2024-03-06 | $180.93K derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $177.60K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $149.11K derived: sum of 2 quarters · filed 2024-03-06 | $334.39K derived: sum of 3 quarters · filed 2024-03-06 | $343.37K 10-K · filed 2024-03-06 |
| 2021-09-30 | -$28.49K 10-Q · filed 2022-11-08 | $156.79K derived: sum of 2 quarters · filed 2022-11-08 | $165.77K 10-Q · filed 2022-11-08 | $175.12K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $185.28K 10-Q · filed 2022-08-09 | $194.26K 10-Q · filed 2022-08-09 | $203.61K derived: sum of 3 quarters · filed 2022-08-09 | $66.97K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $8.98K 10-Q · filed 2022-05-10 | $18.33K derived: sum of 2 quarters · filed 2022-05-10 | -$118.32K derived: sum of 3 quarters · filed 2022-05-10 | -$270.42K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $9.35K 10-K · filed 2021-03-01 | -$127.29K derived: sum of 2 quarters · filed 2021-11-09 | -$279.40K derived: sum of 3 quarters · filed 2021-11-09 | -$704.90K 10-K · filed 2023-03-01 |
| 2020-09-30 | -$136.64K 10-Q · filed 2021-11-09 | -$288.75K derived: sum of 2 quarters · filed 2021-11-09 | -$714.25K 10-Q · filed 2021-11-09 | -$450.68K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$152.10K 10-Q · filed 2021-08-09 | -$577.60K 10-Q · filed 2021-08-09 | -$314.03K derived: sum of 3 quarters · filed 2021-08-09 | -$173.07K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$425.50K 10-Q · filed 2021-05-10 | -$161.93K derived: sum of 2 quarters · filed 2021-05-10 | -$20.97K derived: sum of 3 quarters · filed 2021-05-10 | $106.54K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $263.57K 10-K · filed 2021-03-01 | $404.53K derived: sum of 2 quarters · filed 2021-03-01 | $532.04K derived: sum of 3 quarters · filed 2021-03-01 | $496.20K 10-K · filed 2022-03-01 |
| 2019-09-30 | $140.96K 10-K · filed 2021-03-01 | $268.47K derived: sum of 2 quarters · filed 2021-03-01 | $232.63K 10-Q · filed 2020-11-09 | -$552.43K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $127.51K 10-K · filed 2021-03-01 | $91.67K 10-Q · filed 2020-08-10 | -$693.39K derived: sum of 3 quarters · filed 2021-03-01 | -$877.44K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$35.84K 10-K · filed 2021-03-01 | -$820.90K derived: sum of 2 quarters · filed 2021-03-01 | -$1.00M derived: sum of 3 quarters · filed 2021-03-01 | -$1.13M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$785.06K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$969.11K derived: sum of 2 quarters · filed 2021-03-01 | -$1.09M derived: sum of 3 quarters · filed 2021-03-01 | -$1.34M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$184.05K 10-Q · filed 2019-11-12 | -$305.90K derived: sum of 2 quarters · filed 2019-11-12 | -$558.80K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$121.84K 10-Q · filed 2019-08-08 | -$374.74K 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | -$197.54K 10-K · filed 2020-03-12 | |||
| 2011-09-30 | $346.97K 10-Q · filed 2011-11-07 | $5.25M derived: sum of 2 quarters · filed 2011-11-07 | $7.57M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $4.90M 10-Q · filed 2011-08-05 | $7.22M 10-Q · filed 2011-08-05 | ||
| 2010-09-30 | $522.76K 10-Q · filed 2011-11-07 | $1.20M derived: sum of 2 quarters · filed 2011-11-07 | $2.23M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $676.18K 10-Q · filed 2011-08-05 | $1.70M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |